Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
STRATEGY AND TACTICS: KNOWING THE DIFFERENCE IN PATENT PORTFOLIO CREATION
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Preissuance Submission Final Rules Published July 17, 2012
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
PTO Rules on Pre-issuance Submissions by Third Parties
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Why Myriad Should Drop Its Appeal
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
"In Leukemia Treatment, Glimpses of the Future" of Medicine and IP
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
PTO Guidelines for Process Claims Involving Laws of Nature
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
"Obamacare" Survives – Including Path to Generic Biologicals
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Lilly Files Amicus Brief in Myriad Remand – With Friends Like This…
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Claim Interpretation for Post-Grant Review and Inter Partes Review under the AIA – Part II
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Claim Interpretation for Post-Grant Review and Inter Partes Review under the AIA – Part I
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
The Right to Amend in Reexamination and Post-Grant Review can be Limited
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)